A detailed history of Nebula Research & Development LLC transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 48,976 shares of BLCO stock, worth $963,847. This represents 0.11% of its overall portfolio holdings.

Number of Shares
48,976
Previous 24,112 103.12%
Holding current value
$963,847
Previous $350 Million 169.85%
% of portfolio
0.11%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.59 - $20.0 $362,765 - $497,280
24,864 Added 103.12%
48,976 $945 Million
Q2 2024

Aug 14, 2024

SELL
$13.6 - $17.06 $224,876 - $282,087
-16,535 Reduced 40.68%
24,112 $350 Million
Q1 2024

May 15, 2024

BUY
$13.68 - $17.6 $556,050 - $715,387
40,647 New
40,647 $703 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.89B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.